Delivery Order SPE2DB22D3501-SPE2DB24FUD42
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide REVLIMID 10 MG CAPSULE 28S. The firm fixed price contract has a potential value of $95,083.23 and a completion date of January 16, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related distribution services in...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $28,245.26 to AmerisourceBergen Drug Corp, a wholly owned subsidiary of AmerisourceBergen Corporation, for the provision of REVLIMID 10 MG CAPSULE 28S. This delivery order contract has a performance period through January 8, 2024. AmerisourceBergen Drug Corp, a for-profit organization, is the prime contractor and will deliver the pharmaceutical product from its corporate office location in...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is to provide REVLIMID 25 MG CAPSULE 100S, a pharmaceutical product, with a potential value of $107,931.18. The contract has a completion date of June 16, 2023. Amerisourcebergen Drug Corp has received numerous federal contract...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide REVLIMID 10 MG CAPSULE 100S. The $160,236.61 delivery order has a completion date of February 15, 2022 and was awarded on January 25, 2022. Amerisourcebergen Drug Corp, the prime contractor, is a leading global pharmaceutical sourcing and distribution services company that has received numerous...
- This is a $37,445.14 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of REVLIMID 25 MG CAPSULE 21S, a pharmaceutical product. The contract has an ultimate completion date of October 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these medical supplies through a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of REVLIMID 10 MG CAPSULE 100S. The firm fixed price contract has a potential value of $106,870.16 and a completion date of June 16, 2022. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical product from its corporate office location in Conshohocken, Pennsylvania. No set-aside...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $106,869.32 contract is for the supply of REVLIMID 5 MG CAPSULE 100S, a pharmaceutical product, with a completion date of May 25, 2022. AmerisourceBergen Drug Corp, a for-profit organization, has received numerous federal contracts to provide pharmaceuticals, medical supplies, and related distribution...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $227,924.70 firm fixed price contract is for the delivery of REVLIMID 10 MG CAPSULE 100S pharmaceutical products. The contract has an end date of October 14, 2022 and was awarded on September 22, 2022. Amerisourcebergen Drug Corp, through its Corporate Office division, provides pharmaceutical products and services to U.S. government...
- The Defense Logistics Agency awarded a firm fixed price delivery order contract worth $34,362.95 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of REVLIMID 25 MG CAPSULE 21S. This contract has a completion date of March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which does not have a set-aside designation. This contract is related to a larger indefinite delivery contract (IDC) awarded by DLA to...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the supply of REVLIMID 10 MG CAPSULE 100S, a prescription medication, with a potential value of $211,225.76 and a performance period through March 13, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUD42Delivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of REVLIMID 5 MG CAPSULE 28S pharmaceutical products. The contract has a potential value of $13,799.97 and a completion date of February 5, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide these pharmaceutical products from its corporate office location in Conshohocken, Pennsylvania. This delivery order contract is not associated with a set-aside program. Amerisourcebergen Drug Corp is a leading global pharmaceutical sourcing and distribution services company that has previously received multiple federal contract awards from the DLA Troop Support Medical to supply pharmaceuticals and medical supplies in support of military treatment programs and facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 1/12/24 |